Obtenga las últimas noticias sobre las acciones de Vaxcyte con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de PCVX

Últimas noticias sobre

VAXCYTE INC

Vaxcyte

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Vaxcyte Inc

News

Press Releases

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

Health Care

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Earnings

Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

Management

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

Vaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV)

Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose

PCVX

Ascentage Pharma Group International - American Depository Shares

Ascentage Pharma Group

Abivax

ACADIA Pharmaceuticals Inc. - Common Stock

ACADIA Pharmaceuticals

Arcellx

ADMA Biologics

Akero Therapeutics

Alkermes

Apellis Pharmaceuticals, Inc. - Common Stock

Apellis Pharmaceuticals

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharma

CRISPR Therapeutics

Cytokinetics, Incorporated - Common Stock

Cytokinetics

Krystal Biotech

Jyong Biotech

Mirum Pharmaceuticals, Inc. - common stock

Mirum Pharmaceuticals

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

Merus

Metsera

Nuvalent

PTC Therapeutics

Protagonist Therapeutics, Inc. - Common Stock

Protagonist Therapeutics

Avidity Biosciences

Soleno Therapeutics

Scholar Rock Holding Corporation - Common Stock

Scholar Rock Holding

TG Therapeutics

Zai Lab Limited - American Depositary Shares

Zai Lab

Needham

Goldman Sachs

B of A Securities

Guggenheim

BTIG

Comments

Vaxcyte Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL